No further details on this right now. US$50bn is a substantial investment from the firm. AstraZeneca plc is a British-Swedish pharmaceutical and biotechnology firmheadquarters in Cambridge, UKVisit investingLive.com (formerly ForexLive.com) for additional, original views. This article was written by Eamonn Sheridan at investinglive.com.